PPH: VanEck Pharmaceutical ETF

PPH News

• 17:10 Market Concentration: Building For More Than One Outcome
• 13:22 Execution of Pharma Tariffs Brings These ETFs Into Focus
• 09:20 Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
• 16:40 Equity Outlook: AI, Higher Rates Raise The Bar For Diversification
• 18:25 Where Healthcare Innovation Meets Investment Opportunity
• 15:37 David Rubenstein Of The Carlyle Group On The Business Of Sports, Investing And Leadership
• 10:18 'Anthropic quietly sets up biology lab as it ramps AI drug program' - Reuters Exclusive
• 10:18 アンソロピックは、AI薬物プログラムを拡大する中で、静かに生物学研究所を設立します - ロイター独占記事
• 15:15 Here's How Trump's Drug Deals Are Likely to Impact Healthcare ETFs
• 16:05 The Market May Be Telling Us We're Entering A Capital Formation Cycle
• 12:20 Trump’s MFN Policy Is Reshaping Global Pharma, Not Prices
• 14:27 Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough
• 14:29 FDA Nods Lilly-Roche's Alzheimer's Blood Test: Healthcare ETFs to Track Now
• 14:55 Where Is Growth?
• 06:45 The Investor Mentality
• 04:10 The Market Is Trying To Tell Us Something About 2027
• 01:10 Healthy And Energized At New Highs
• 04:30 Nearly A Third Of Tech Has Raised Guidance
• 04:30 Is The S&P 500's Concentrated Rally Starting To Diversify?
• 05:20 Health Care Shakes Off A 5-Day Slide
• 10:20 Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
• 12:53 Will Generic Drug Tariffs Impact Pharma ETFs?
• 03:58 Health Care's Clean Bill Of Breadth
• 12:25 Healthcare Systems' Liquidity Challenge